Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-19

Clinical Trial Update: Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study investigating intravenous oxytocin for analgesia to heat pain in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Healthy Volunteer Study | Phase 2 | Status: COMPLETED | Results posted: 2024-03-19